KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
000739 Apeloa Pharmaceutical
- 16.27
- -0.37-2.22%
Market Closed Dec 13 15:00 CST
19.02BMarket Cap17.72P/E (TTM)
16.56High16.26Low65.83KlotVolume16.56Open16.64Pre Close107.77MTurnover0.56%Turnover Ratio18.02P/E (Static)1.17BShares18.9652wk High2.89P/B19.02BFloat Cap10.3552wk Low18.30Limit Up1.17BShs Float40.98Historical High14.98Limit Down1.80%Amplitude-1.06Historical Low0.32Dividend TTM16.37Avg Price37.91KlotAsk1.95%Div YieldTTM100Lot Size25.00KlotBid
Apeloa Pharmaceutical News
Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate
Pro-Pharmaceuticals: Announcement on Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Prologis Pharmaceutical: 2024-58. Announcement on signing a strategic cooperation framework agreement
Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate
Pro-Pharmaceuticals: Announcement on Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Pro-Pharmaceuticals: Notice on Obtaining a Notice of Approval for Drug Supplementary Applications
Pro-Pharmaceuticals: Announcement on Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Pro-Pharmaceuticals: Announcement on Obtaining a Drug Registration Certificate
Pro-Pharmaceuticals: Notice on Obtaining a Notice of Approval for Drug Supplementary Applications
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Prologis Pharmaceuticals: Investor Relations Activity Record Form for October 18, 2024
Prologis Pharmaceuticals: Report for the third quarter of 2024
Prologis Pharmaceuticals: Announcement on amantadine hydrochloride tablets being approved for marketing by the US FDA
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Prologis Pharmaceutical: Announcement on the expiration of the share repurchase period and the implementation results of the repurchase
Prologis Pharmaceuticals: Announcement on the signing of a strategic cooperation framework agreement
Prologis Pharmaceutical: Announcement on foreign investment of subsidiary companies
Prologis Pharmaceuticals: Progress Announcement on the Repurchase of the Company\'s Shares
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
